Germany Outbound Tourism Market Research Report

Germany presents an attractive set of conditions making investment possible. Despite a Global recession, Germany has not been in bad shape in Germany outbound tourism market. The number of Germany outbound tourists is forecasted to reach nearly 5 Million by 2020. Additionally, Germany outbound tourists spending was nearly 11 Billion in 2015.

Germany Outbound Tourists Visit Analysis: United States has emerged as the most popular tourist destination for German travelers. In 2015, XXXX% of the total Germany outbound tourists visited United States. It is predicted that United States will be leading destination for the German travelers by the year 2020. China and Singapore were at the 2nd and 3rd popular destination for German travelers with XXX% and XXX% share respectively in 2015.

Germany Outbound Tourism Spending Analysis: United States is the leader with XXX% of spending in 2015 by the German Tourists. German tourists spending share in United States is higher than the combined share of the top 9 tourism destination. United States is likely to maintain dominance in Germany outbound tourism spending but its share is expected to tumble down to XXX% by the year 2020, as German tourists are now exploring various other destinations.  China and Australia accounted for XXX% and XXX% share of total outbound spending by Germany in 2015. It is projected that China and Australia will have spending share of XXX% and XXX% respectively in 2020. In the year 2015, India was standing at fourth spot in terms of spending by German tourists being followed by New Zealand in 2015.

DPI Researchreport entitled Germany Outbound Tourism Market: Outbound Tourists Visit, Tourists Spending & Forecastprovides a comprehensive assessment of the fast-evolving, high-growth Germany outbound travel industry. This report provides a complete analysis of top 10 countries worldwide for German tourists. All the country in the report has been studied from three view points

1)    Germany outbound tourists to top 10 countries

2)    Germany outbound tourists market (spending) in top 10 countries

3)    Germany outbound tourists purpose of visit (Business, Holiday/Leisure, VFR & Others)

Countries Analysed

Top 10 Countries:Singapore, United States, Australia, China, Japan, South Africa, Korea, New Zealand, Cambodia and India

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources:Questionnaires, Surveystelephonic interviews with industry experts and Observations

Secondary Sources:Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

Read More Details @ http://www.dpiresearch.com/report-details.php?P_ID=48

Non-Invasive Prenatal Testing Market Report 2018

Non-Invasive Prenatal Test (NIPT)are targeted at the detection of certain specific chromosomal aneuploidies from maternal blood sample in pregnant women at high risk for fetal aneuploidies. Currently, the prenatal testing market is experiencing a paradigm shift from conventional prenatal screening and diagnostic methods to non-invasive prenatal testing. This is mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities.

NIPT is one of the most promising new areas of screening because it delivers highly actionable insights for empowering critical health decisions. The global non-invasive prenatal testing market is segmented on the basis of tests viz; Harmony, MaterniT21 PLUS, PrenaTest, Verifi, BambniTest, Panorama, InformaSeq, Non-Invasive Fetal Trisomy Test (NIFTY), VisibiliT, Veracity and IONA Test. NIPT has experienced substantial growth over the past few years.

MaterniT21 plus test has gain its momentum in 2011 when there was only one NIPT test available in the market. In 2015, The MaterniT21 plus test market revenue decreased with XXX% compared to 2014. MaterniT21 test market revenue value was US$ XXX Million in 2015. Natera has emerged as one of the leading companies, with innovative technologies and a strong commercial base. Natera Panorama test will lead the NIPT market in the forecasting period with the market share of XXX% by the year 2021. Other NIPT tests such as Harmony, Verifi and NIFTY have emerged as the promising test in the NIPT test market. The major companies are expanding their tests through Collaboration, Distribution Agreement, Strategic Alliances and Partnerships with Clinical Laboratories and Hospitals.

DPI Research report titled “Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) – Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021″. The report presents a comprehensive study of the Global NIPT market with market revenue and volume of the tests. market shares for leading NIPT test, comparative analysis of the non–invasive prenatal testing,NIPT implementation in HICs and LMICs, major deals in the NIPT market such as Collaborations, Partnerships, Distribution Agreement, Venture Capital Investment, Merger & Acquisition, Licensing Agreement and Exclusive Agreement. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

Key segments of the Global NIPT market

The 11 NIPT Test covered in the report has been analyzed from 2 viewpoints:

1. NIPT Test Market Revenue (2011 – 2021)

2. NIPT Test Volume (2011 – 2021)

The following are the NIPT test name which is covered in the report.

1)    BambniTest

2)    Harmony

3)    informaSeq

4)    MaterniT21 PLUS

5)    NIFTY

6)    Panorama

7)    PrenaTest

8)    verifi

9)    VisibiliT

10)  Veracity

11)  IONA Test

The report also covers NIPT implementation in High Income Countries and Low – or- Middle Income Countries. The 3 issues for implementation covered are:

1)    Clinical Issues

2)    Ethical Issues

3)    Legal and Regulatory Issues

This report gives access to significant data such as:

  •    Market Growth Drivers
  •    Challenges in the NIPT Test Market
  •    Current Market Trends
  •    Market Forecasting for the Coming Years
  •    Comparative Test Analysis

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources:Questionnaires, Surveystelephonic interviews with industry experts and Observations

Secondary Sources:Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

Read More Details @ http://www.dpiresearch.com/report-details.php?P_ID=49

Global Insulin Delivery Pen Market Analysis

Insulin Delivery Pen Market is expected to exceed US$ 14 Billion across the ten major markets (10MM) by 2025.
The report “Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 – 2017) and Future Forecast (2018 – 2025)” offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM). The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.
Key Findings:
• Germany accounted for 15% of the insulin delivery pen market in 2017
• China dominates the reusable insulin delivery pen market
• Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
• Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
• Japan is the third largest insulin delivery pen market
• Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector
The Latest Industry Data Included in this Report:
• Diabetes Population in 10 major market(10MM) 2011-2025
• Insulin Users Insights in 10 major market(10MM) 2011-2025
• Overall Insulin Delivery Pen Users, 2011-2025
• Overall Insulin Delivery Pen Market Size, 2011-2025
• Insulin Delivery Pen Market Size by Product Segments, 2011-2025
• Growth Rates of the Overall Market and Different Product Segments, 2011-2025
• Shares of Different Product Segments of the Overall Market, 2011- 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
   and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
  Product Portfolios and Recent Development
The Report Facilitates Answer the Subsequent Questions:
• What is the size of the insulin delivery pen market in 10 major market(10MM)?
• How much reusable and disposable pen users in 10 major market(10MM)?
• How is the insulin delivery pen market divided into two different types of segments?
• How are the overall market and segments types growing?
• How is the market predicted to develop in the future?
• Who are the market players?